201 related articles for article (PubMed ID: 10226872)
1. Disodium cromoglycate does not prevent terbutaline-induced desensitization of beta 2-adrenoceptor-mediated cardiovascular in vivo functions in human volunteers.
Schäfers RF; Piest U; von Birgelen C; Jakubetz J; Daul AE; Philipp T; Brodde OE
J Cardiovasc Pharmacol; 1999 May; 33(5):822-7. PubMed ID: 10226872
[TBL] [Abstract][Full Text] [Related]
2. Terbutaline-induced desensitization of human cardiac beta 2-adrenoceptor-mediated positive inotropic effects: attenuation by ketotifen.
Poller U; Fuchs B; Gorf A; Jakubetz J; Radke J; Pönicke K; Brodde OE
Cardiovasc Res; 1998 Oct; 40(1):211-22. PubMed ID: 9876334
[TBL] [Abstract][Full Text] [Related]
3. Terbutaline-induced desensitization of beta 2-adrenoceptor in vivo function in humans: attenuation by ketotifen.
Brodde OE; Petrasch S; Bauch HJ; Daul A; Gnadt M; Oefler D; Michel MC
J Cardiovasc Pharmacol; 1992 Sep; 20(3):434-9. PubMed ID: 1279289
[TBL] [Abstract][Full Text] [Related]
4. Ketotifen and cardiovascular effects of xamoterol following single and chronic dosing in healthy volunteers.
Schäfers RF; Karl I; Mennicke K; Daul AE; Philipp T; Brodde OE
Br J Clin Pharmacol; 1999 Jan; 47(1):59-66. PubMed ID: 10073741
[TBL] [Abstract][Full Text] [Related]
5. beta2-Adrenoceptor desensitization in human alveolar macrophages induced by inhaled terbutaline in vivo is not counteracted by budesonide.
Zetterlund A; Hjemdahl P; Larsson K
Clin Sci (Lond); 2001 Apr; 100(4):451-7. PubMed ID: 11256987
[TBL] [Abstract][Full Text] [Related]
6. Cardiac effects of beta-adrenoceptor antagonists with intrinsic sympathomimetic activity in humans: beta1- and/or beta2-adrenoceptor mediated?
Jakubetz J; Schmuck S; Poller U; Fuchs B; Gorf A; Radke J; Pönicke K; Brodde OE
J Cardiovasc Pharmacol; 1999 Mar; 33(3):461-72. PubMed ID: 10069683
[TBL] [Abstract][Full Text] [Related]
7. Desensitization of beta2-adrenoceptor-mediated responses by short-acting beta2-adrenoceptor agonists in human lung mast cells.
Chong LK; Suvarna K; Chess-Williams R; Peachell PT
Br J Pharmacol; 2003 Feb; 138(3):512-20. PubMed ID: 12569076
[TBL] [Abstract][Full Text] [Related]
8. Terbutaline-induced desensitization of human lymphocyte beta 2-adrenoceptors. Accelerated restoration of beta-adrenoceptor responsiveness by prednisone and ketotifen.
Brodde OE; Brinkmann M; Schemuth R; O'Hara N; Daul A
J Clin Invest; 1985 Sep; 76(3):1096-101. PubMed ID: 2995446
[TBL] [Abstract][Full Text] [Related]
9. Studies in vivo and in vitro of terbutaline-induced beta-adrenoceptor desensitization in healthy subjects.
Martinsson A; Larsson K; Hjemdahl P
Clin Sci (Lond); 1987 Jan; 72(1):47-54. PubMed ID: 3026718
[TBL] [Abstract][Full Text] [Related]
10. The Gln27Glu beta2-adrenoceptor polymorphism slows the onset of desensitization of cardiac functional responses in vivo.
Bruck H; Leineweber K; Büscher R; Ulrich A; Radke J; Insel PA; Brodde OE
Pharmacogenetics; 2003 Feb; 13(2):59-66. PubMed ID: 12563174
[TBL] [Abstract][Full Text] [Related]
11. Chronic terbutaline treatment desensitizes beta-adrenergic inhibition of lymphocyte activation in healthy volunteers.
Werner C; Poller U; Brodde OE
J Auton Pharmacol; 1997 Aug; 17(4):237-42. PubMed ID: 9373782
[TBL] [Abstract][Full Text] [Related]
12. Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol.
Brodde OE; Daul A; Michel-Reher M; Boomsma F; Man in 't Veld AJ; Schlieper P; Michel MC
Circulation; 1990 Mar; 81(3):914-21. PubMed ID: 1968366
[TBL] [Abstract][Full Text] [Related]
13. Positive inotropic effects of the beta 2-adrenoceptor agonist terbutaline in the human heart: effects of long-term beta 1-adrenoceptor antagonist treatment.
Schäfers RF; Adler S; Daul A; Zeitler G; Vogelsang M; Zerkowski HR; Brodde OE
J Am Coll Cardiol; 1994 Apr; 23(5):1224-33. PubMed ID: 8144793
[TBL] [Abstract][Full Text] [Related]
14. Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors.
Heubach JF; Blaschke M; Harding SE; Ravens U; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):380-90. PubMed ID: 12690430
[TBL] [Abstract][Full Text] [Related]
15. Beta 2-agonist treatment reduces beta 2-sensitivity in alveolar macrophages despite corticosteroid treatment.
Hjemdahl P; Zetterlund A; Larsson K
Am J Respir Crit Care Med; 1996 Feb; 153(2):576-81. PubMed ID: 8564101
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase PDE2 activity, increased by isoprenaline, does not reduce β-adrenoceptor-mediated chronotropic and inotropic effects in rat heart.
Galindo-Tovar A; Vargas ML; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2018 Jun; 391(6):571-585. PubMed ID: 29556684
[TBL] [Abstract][Full Text] [Related]
17. Effects of beta 2-agonist- and dexamethasone-treatment on relaxation and regulation of beta-adrenoceptors in human bronchi and lung tissue.
Hauck RW; Harth M; Schulz C; Präuer H; Böhm M; Schömig A
Br J Pharmacol; 1997 Aug; 121(8):1523-30. PubMed ID: 9283684
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects.
Ferro A; Hall JA; Dickerson JE; Brown MJ
Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenoceptor control of G protein function in the neonate: determinant of desensitization or sensitization.
Auman JT; Seidler FJ; Slotkin TA
Am J Physiol Regul Integr Comp Physiol; 2002 Nov; 283(5):R1236-44. PubMed ID: 12376418
[TBL] [Abstract][Full Text] [Related]
20. Protection by dexamethasone of the functional desensitization to beta 2-adrenoceptor-mediated responses in human lung mast cells.
Chong LK; Drury DE; Dummer JF; Ghahramani P; Schleimer RP; Peachell PT
Br J Pharmacol; 1997 Jun; 121(4):717-22. PubMed ID: 9208139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
